GlassScriptPhysician profile
Maria L Castillo
NPI 1184924144
$2,333.31
in general payments reported to CMS, 2019-2025
21 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $393 · 2022: $639 · 2023: $888 · 2024: $140 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $934.59 | 2021-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $374.19 | 2021-2024 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $135.56 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $112.50 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Biohaven Pharmaceutical Holding Company LTD. | $108.24 | 2022 | |
| Corcept Therapeutics | $104.48 | 2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $73.57 | 2022-2023 | |
| Pfizer INC. | $72.12 | 2023-2024 | |
| Redhill Biopharma INC. | $61.94 | 2021-2025 | Talicia |
| Exact Sciences Corporation | $57.64 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $47.35 | 2021 | |
| Lilly USA, LLC | $47.27 | 2024-2025 | Mounjaro |
| Phadia US INC. | $39.63 | 2022-2023 | Immunocap |
| Otsuka America Pharmaceutical, INC. | $27.88 | 2023 | Jynarque |
| Abbott Laboratories | $27.65 | 2023 | Freestyle Libre 3 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.57 | 2025 | Repatha, Otezla |
| Dexcom, INC. | $19.77 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.94 | 2025 | Jardiance |
| Cranial Technologies, INC | $16.93 | 2023 | Doc Band |
| Edwards Lifesciences Corporation | $16.57 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Agile Therapeutics, INC. | $13.92 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.